ROSEN, LEADING INVESTOR COUNSEL, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Secur

  • NEW YORK CITY, NY / ACCESS Newswire / April 23, 2025 / WHY: New York, N.Y., April 23, 2025.